CollPlant Biotechnologies Ltd Deferred Tax Assets, Operating Loss Carryforwards
CollPlant Biotechnologies Ltd (CLGN) had Deferred Tax Assets, Operating Loss Carryforwards of $24.52 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $24.52M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $18.68M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.49M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $20.11M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $24.52M 20-F · filed 2026-03-26 | |
| 2024-12-31 | $18.68M 20-F · filed 2026-03-26 | |
| 2023-12-31 | $15.49M 20-F · filed 2025-03-26 | |
| 2022-12-31 | $20.11M 20-F · filed 2024-04-04 | |
| 2021-12-31 | $14.39M 20-F · filed 2023-03-29 | |
| 2020-12-31 | $14.69M 20-F · filed 2022-03-24 | $13.17M 20-F · filed 2021-03-26 |
| 2019-12-31 | $12.61M 20-F · filed 2021-03-26 |